Vanguard Value Index Fund ETF (VTV) Stock Price Today
Key Stats
- -MARKET_CAP
- -VOLUME
- -SECTOR
- $220.51FIFTY_TWO_WEEK_HIGH
- $175.51FIFTY_TWO_WEEK_LOW
- -TYPICAL_HOLD_TIME
- -ENTERPRISE_VALUE
- -DIVIDEND_YIELD
- -TRADING_ACTIVITY
Track Vanguard Value Index Fund ETF (VTV) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vanguard Value Index Fund ETF has traded between a low of $175.51 and a high of $220.51, highlighting its annual price range. Buy and sell Vanguard Value Index Fund ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vanguard Value Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Value Index, a broadly diversified index predominantly made up of value stocks of large US companies. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Most Recent News
Wedbush celebrates 18 years with Cboe, highlighting market innovation and expanding digital asset trading.
Wedbush rang the closing bell at Cboe Global Markets to mark 18 years as a Cboe member, celebrating a partnership focused on innovation and market integrity. Since joining in 2008, Wedbush has supported the evolution of financial markets through new ...

Lawsuit challenges government-led censorship of Covid vaccine injury discussions on social media.
The New Civil Liberties Alliance (NCLA) filed an appeal to revive a lawsuit against the Biden Administration and private companies for censoring social media posts by individuals injured by Covid vaccines. Plaintiffs, including vaccine-injured indivi...

Investigation launched into Alignment Healthcare over alleged financial manipulation claims.
Hagens Berman has started investigating Alignment Healthcare after a whistleblower lawsuit accused the company of misclassifying expenses to inflate financial results for 2024 and 2025. The allegations claim this manipulation boosted key metrics, aff...
